ScoreWhy is Kwality Pharmaceuticals Ltd ?
1
Strong ability to service debt as the company has a low Debt to EBITDA ratio of 1.10 times
2
With a growth in Net Profit of 114.93%, the company declared Outstanding results in Jun 26
- The company has declared positive results for the last 10 consecutive quarters
- OPERATING PROFIT TO INTEREST(Q) Highest at 15.42 times
- ROCE(HY) Highest at 21.92%
- INVENTORY TURNOVER RATIO(HY) Highest at 6.43 times
3
Increasing Participation by Institutional Investors
- Institutional investors have increased their stake by 0.54% over the previous quarter and collectively hold 3.69% of the company
- These investors have better capability and resources to analyse fundamentals of companies than most retail investors
4
Consistent Returns over the last 3 years
- Along with generating 176.42% returns in the last 1 year, the stock has outperformed BSE500 in each of the last 3 annual periods
Real-Time Research ReportHow much should you buy?
- Overall Portfolio exposure to Kwality Pharma should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Kwality Pharma for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
Kwality Pharma
176.42%
3.29
53.61%
Sensex
-1.65%
-0.13
13.58%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
2.48%
EBIT Growth (5y)
-11.57%
EBIT to Interest (avg)
16.48
Debt to EBITDA (avg)
1.14
Net Debt to Equity (avg)
0.38
Sales to Capital Employed (avg)
0.98
Tax Ratio
24.75%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
3.69%
ROCE (avg)
17.72%
ROE (avg)
77.82%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
39
Industry P/E
37
Price to Book Value
8.01
EV to EBIT
28.28
EV to EBITDA
23.54
EV to Capital Employed
6.07
EV to Sales
5.53
PEG Ratio
0.55
Dividend Yield
NA
ROCE (Latest)
21.47%
ROE (Latest)
20.49%
Loading Valuation Snapshot...
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
Bearish
Bearish
Bollinger Bands
Mildly Bullish
Mildly Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Bullish
Dow Theory
Mildly Bearish
Bullish
OBV
Mildly Bullish
No Trend
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend42What is working for the Company
OPERATING PROFIT TO INTEREST(Q)
Highest at 15.42 times
ROCE(HY)
Highest at 21.92%
INVENTORY TURNOVER RATIO(HY)
Highest at 6.43 times
PBDIT(Q)
Highest at Rs 41.01 cr.
OPERATING PROFIT TO NET SALES(Q)
Highest at 25.26%
PBT LESS OI(Q)
Highest at Rs 33.37 cr.
PAT(Q)
Highest at Rs 25.62 cr.
NET SALES(Q)
Highest at Rs 162.35 cr
EPS(Q)
Highest at Rs 24.68
-2What is not working for the Company
CASH AND CASH EQUIVALENTS(HY)
Lowest at Rs 3.59 cr
DEBTORS TURNOVER RATIO(HY)
Lowest at 1.80 times
Loading Valuation Snapshot...
Here's what is working for Kwality Pharma
Operating Profit to Interest - Quarterly
Highest at 15.42 times and Grown
each quarter in the last five quartersMOJO Watch
The company's ability to manage interest payments is improving
Operating Profit to Interest
Profit Before Tax less Other Income (PBT) - Quarterly
At Rs 33.37 cr has Grown at 100.42%
Year on Year (YoY)MOJO Watch
Near term PBT trend is very positive
PBT less Other Income (Rs Cr)
Profit After Tax (PAT) - Quarterly
At Rs 25.62 cr has Grown at 114.8%
Year on Year (YoY)MOJO Watch
Near term PAT trend is very positive
PAT (Rs Cr)
Net Sales - Quarterly
At Rs 162.35 cr has Grown at 45.63%
Year on Year (YoY)MOJO Watch
Near term sales trend is very positive
Net Sales (Rs Cr)
Operating Profit (PBDIT) - Quarterly
Highest at Rs 41.01 cr. and Grown
each quarter in the last five quartersMOJO Watch
Near term Operating Profit trend is quite positive
Operating Profit (Rs Cr)
Operating Profit Margin - Quarterly
Highest at 25.26% and Grown
each quarter in the last five quartersMOJO Watch
Company's efficiency has improved
Operating Profit to Sales
Profit Before Tax less Other Income (PBT) - Quarterly
Highest at Rs 33.37 cr. and Grown
each quarter in the last five quartersMOJO Watch
Near term PBT trend is very positive
PBT less Other Income (Rs Cr)
Profit After Tax (PAT) - Quarterly
Highest at Rs 25.62 cr. and Grown
each quarter in the last five quartersMOJO Watch
Near term PAT trend is very positive
PAT (Rs Cr)
Inventory Turnover Ratio- Half Yearly
Highest at 6.43 times and Grown
each half year in the last five half yearly periodsMOJO Watch
Company has been able to sell its inventory faster
Inventory Turnover Ratio
Net Sales - Quarterly
Highest at Rs 162.35 cr
in the last five quartersMOJO Watch
Near term sales trend is positive
Net Sales (Rs Cr)
Earnings per Share (EPS) - Quarterly
Highest at Rs 24.68
in the last five quartersMOJO Watch
Increasing profitability; company has created higher earnings for shareholders
EPS (Rs)
Here's what is not working for Kwality Pharma
Cash and Cash Equivalents - Half Yearly
Lowest at Rs 3.59 cr
in the last six half yearly periodsMOJO Watch
Short Term liquidity is deteriorating
Cash and Cash Equivalents
Debtors Turnover Ratio- Half Yearly
Lowest at 1.80 times
in the last five half yearly periodsMOJO Watch
Company's pace of settling its Debtors has slowed
Debtors Turnover Ratio
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
